7H) These results indicate that NS depletion predisposes prolife

7H). These results indicate that NS depletion predisposes proliferating hepatocytes to replication-dependent DNA damage by perturbing RAD51 recruitment to DNA damage foci. The importance of NS in liver development is shown by the increase of spontaneous DNA damage, apoptosis, BDH, and fibrosis in albNScko livers. DNA damage appears first in albNScko livers during the first to second postnatal week, followed by an increase of apoptotic cells that peaks at 3 weeks of age and the appearance of necrotic foci and regenerative

hepatic nodules. Complete loss of NS proteins by albNScko occurs within http://www.selleckchem.com/products/gsk1120212-jtp-74057.html the first week after birth and mainly affects developing hepatocytes. Although we cannot exclude the possibility that the Alb-Cre transgene is expressed in subsets of BECs, our data indicate that most BECs do not show Alb-Cre activity. see more This may explain why biliary hyperplasia becomes a prominent feature in adult albNScko livers. Newly generated hepatocytes in albNScko livers form small nodules and display basophilic cytoplasm and multiple small nucleoli. These cells also show higher mitotic activity and NS-positive expression and are less developmentally mature (as evidenced

by their AFP-positive and PAS-negative staining), compared to nonregenerative hepatocytes outside the nodule. The close spatial association between the regenerative nodules and periportal areas suggests that newly generated hepatocytes may be derived from non-NS-deficient click here BECs or HSPCs. In support of this, albNScko livers display increased HSPC-related proteins and the expansion of A6 and CK19 double-positive cells. These findings suggest that HSPCs may be activated by albNScko-induced liver damage. To date, only

a handful of mouse genetic models exhibit the phenotype of robust HSPC activation.[22-25] Compared to those published, the albNScko model has the unique features of an early-onset expansion of HSPCs (within 4 weeks of age) and long-term survival (over 1 year). The role of NS in liver regeneration is shown by the increased NS expression and the response of albNScko livers to CCl4 and PHx. In addition to the phenotypes of acute pericentral necrosis and leukocyte infiltration observed in NSflx/flx livers, CCl4 triggers severe hydropic degeneration in NS-deleted nonregenerative hepatocytes. In contrast, hepatocytes within the regenerative nodules are relatively resistant to the acute necrosis caused by CCl4, which may be explained by their less-differentiated features and lower expression of CYP2E1. Subsequent to CCl4-induced damage, mitotic cells are increased in the BDE, regenerative nodules, and nonregenerative hepatocytes of albNScko livers.

For TTH, the 2010 European Federation of Neurological Societies g

For TTH, the 2010 European Federation of Neurological Societies guidelines on the treatment of TTH97 states that non-pharmacological modalities should always be considered, although the scientific evidence is limited. http://www.selleckchem.com/products/DAPT-GSI-IX.html The available evidence shows that EMG BFB is effective, and cognitive behavioral therapy and relaxation

training most likely are effective as well for TTH treatment. Behavioral treatment may be administered in clinic-based, limited-contact, and home-based formats, and patients may be seen individually or as part of a group. Limited-contact treatment usually involves 3 or 4 monthly treatment sessions during which skills are introduced. Audiotapes and manuals are subsequently used at home for practicing and refining skills, with clinicians assisting occasionally via telephone. Limited-contact, home-based, and clinic-based treatment formats have demonstrated similar results when compared directly98-100 or by meta-analysis.101 Furthermore, the cost-effectiveness of home-based treatments has been found to be more than 5 times that of clinic-based therapies.101 Biofeedback Pictilisib research buy Biofeedback is a common intervention utilized in the treatment of pain disorders. It involves the monitoring and voluntary control

of physiologic processes, allowing patients to take an active role in managing their pain. This in turn results in improved coping with the psychological and psychosocial consequences of their condition. BFB is often combined with relaxation and cognitive behavioral

strategies such as stress management. Different types of BFB are used depending on the patient’s diagnosis. All forms of BFB involve the conversion of biologic or physiologic information into a signal that is then “fed back” in auditory form (such as clicks varying in rate) or visual form (such as bars varying in length). In migraine, peripheral skin temperature feedback (TEMP-FB), blood-volume-pulse feedback (BVP-FB) and electromyographic feedback (EMG-FB) are most commonly used. For TTH, EMG-FB, which is directed at reducing pericranial muscle activity, is the most frequently applied behavioral treatment modality.102 Relaxation skills such as diaphragmatic breathing or visualization are usually taught selleck inhibitor in conjunction with BFB to produce a relaxation response. BFB training usually involves 8-12 office visits spaced 1 to several weeks apart, although evidence suggests that treatment can be effective in a reduced-contact or home-based approach.101 Once the patient has developed the skills necessary to control targeted physiologic processes, the BFB device can be eliminated. BIOFEEDBACK FOR MIGRAINE TREATMENT A 2007 meta-analysis,103 which included 55 studies, provided strong evidence for the efficacy of BFB in the preventative treatment of migraine.

“Summary  Persistence of inhibitors against factor VIII (

“Summary.  Persistence of inhibitors against factor VIII (FVIII) may be a risk factor that increases physical disability in haemophilia A (HA) patients. This study aimed to evaluate prevalence of FVIII inhibitors in previously treated children with severe HA and the impact of persistent inhibitors

on knee joint status and lumbar bone mineral density (BMD). Fifty children with severe HA, FVIII <1%; aged 5–16 years were enrolled in this study; they received plasma-derived FVIII on-demand treatment for 50–250 exposure days (EDs). Inhibitors were checked at http://www.selleckchem.com/products/jq1.html basal visit and were followed up for 1 year, using Bethesda assay. Cross-sectional clinical scoring and radiological evaluation of the knee joint (by Arnold-Hilgartner staging and Pettersson score), along with lumbar BMD by Dual Energy X-ray Absorptiometry (DEXA) were performed. Patients with persistent inhibitors for 1 to 5 years, median 2.5 years, were 10 (20%). Six had high titre and none of them had completely normal knees, seven had advanced knee arthropathy and six had low lumbar BMD in comparison to 2 and 8 of the 40 patients without inhibitors respectively (P < 0.05). Persistence of inhibitors for more than 2 years without immuno-prophylaxis was a risk factor for joint damage. Low lumbar BMD was found in

88.9% of patients with stages four and five knee arthropathy and in 66.7% of patients with positive hepatitis C. Severe HA children in this Egyptian study had a relatively low prevalence of persistent FVIII inhibitors, which, if not selleck treated, may increase the risk of knee arthropathy and lumbar osteopenia. “
“The increasing emphasis on home-based treatment for the management of children with haemophilia has meant that many of these children no longer regularly report to a medical facility. Consequently, it is difficult to monitor incidence of bleeding episodes. The aim of this study was to assess the feasibility of using a short message service (SMS) to monitor incidence of bleeding episodes in children with haemophilia. One hundred

and four children with moderate and severe learn more haemophilia A or B took part in a 1-year prospective study between 2008 and 2010. Children or their parents were asked to maintain a bleeds diary. They received a weekly SMS asking whether there had been a bleeding episode in the preceding week. Response rates were calculated. Children were followed for a total of 4839 person-weeks. SMS replies were received for 4201 weeks. Thus, the rate of follow-up was 86.8%. Median responses rates were 94.2% (IQR: 86.1–100%). Weekly SMS is a feasible reporting tool for documenting bleeding episodes in children with haemophilia. It is associated with high response rates and minimal expense and intrusion. The use of SMS could be extended to encourage compliance to prophylactic treatment, particularly in adolescents with haemophilia. “

The mean scores of OHR-QoL in percentage are presented in Table 3

The mean scores of OHR-QoL in percentage are presented in Table 3. The participants were divided into three age groups (2–7, 8–10 and 11–15), and the percentage of means was compared. The one-sample Kolmogorov–Smirnov test revealed the skewed distribution for ECOHIS and CPQ, and hence comparison was made by Mann–Whitney test. OIDP was analysed by Independent t-test

due to its normal distribution. Statistical comparisons between total and domains of ECOHIS JNK inhibitor and CPQ are presented in Tables 4-6. Neither the specific domains nor the items were significantly different between groups except for CPQ items 23–24 (teasing or being asked about teeth by peers in the age group of 8–10 years), wherein CBD patients were found to have a better situation (Independent t-test; P = 0.2 and P = 0.000). t = −0.73, df = 26.7 P = 0.47 t = 0.20, ICG-001 datasheet df = 20.09 P = 0.85 t = 1.03, df = 36 P = 0.32 t = −1.1, df = 36 P = 0.27 t = 0.385, df = 24.19 P = 0.7 NS Maintaining oral health is a priority in CBD patients. According to the results of this study, during primary dentition, young

CBD patients were more caries-free. In addition, the total number of decayed primary and permanent tooth surfaces was significantly lower in CBD. Dental situation (DMFS-DMFT scores) in 11–15-year-old CBD patients was similar to that of controls; however, when compared with a previous Iranian study [14], a much lower DMFS score is found[14]. This fact per se reflects the supportive care that CBD patients have received at young age from the CBD care centre, including exposure to topical fluoride, obligatory dental visits, regular education of patients and parents, and finally, oral reconstruction under general anaesthesia that is scheduled as a part of establishment and development of comprehensive CBD healthcare programme during the recent years [15]. It seems that older patients (11–15 years of age) may be less benefited from recent facilities. On the other hand, this finding may be attributed to selleck inhibitor their adolescent period when frequent eating, more snack consumption and less parental supervision are observed. In addition, emotional distresses during this period are

blamed for salivary dysfunction and less resistance to caries [16], and their dental scores more resembled those of healthy controls. There is no consensus among the investigators with regard to dental and oral health, as well as to quality of life of CBD patients. Results similar to those of the present study have been reported in studies from England, Ireland, Germany and Egypt [17-20]; however, a poorer dental situation in CBD patients compared with controls is found in Poland, Turkey and India [20-23]. Inconsistency in the level of provided health care in different communities is probably the main causative factor. With regard to other variables including TMJ dysfunction, we could not detect more TMJ problems compared with healthy individuals.

This probably relates to the fact that clinical decompensation is

This probably relates to the fact that clinical decompensation is related to the severity of portal hypertension and selleck products synthetic dysfunction. Individual ALT and AST values correlate better with underlying necroinflammation and have been shown to be predictive of fibrosis progression.7, 14 The AST/ALT ratio has been shown to be a predictor of cirrhosis15 but not of hepatic synthetic dysfunction.11 It is possible that if changes in AST and ALT occur

in the same direction, it would have a minimal effect on the AST/ALT ratio. Thus, monitoring the AST/ALT ratio was not found to be helpful in predicting a clinical decompensation outcome. A model including baseline platelet count and albumin together with worsening serum albumin and AST/ALT ratio (Model IIIB) was the best predictor of find more liver-related death or liver transplant. Interestingly, neither baseline

serum bilirubin nor change in bilirubin level over 24 months was predictive of liver-related death or liver transplant. This may be related to the fact that a substantial number of deaths and liver transplants in this analysis were due to HCC and not decompensation. Removal of HCC as an outcome resulted in bilirubin being a significant predictor of liver-related outcomes. Many models have been developed to predict severity of fibrosis and cirrhosis in patients with chronic hepatitis C. Only a few have looked at clinical outcomes but these models have used laboratory tests that are not widely available or the sample size has been small with limited follow-up.16 The strength of click here this study was the large number of patients who were prospectively monitored for over 8 years for liver outcomes and each outcome was adjudicated by

a review panel. The combined model using baseline laboratory values in combination with a change in the laboratory value over a 24-month period was the most accurate at predicting risk of a clinical outcome. We chose not to consider the most recent laboratory values when determining whether a change in laboratory values was important. This analytic approach would necessitate selecting an arbitrary timepoint as “current.” Moreover, the approach we selected more closely resembles that used in clinical practice, beginning with a baseline laboratory value and monitoring the change prospectively. We selected a 24-month period for calculating change in laboratory values from baseline. This was a compromise over an earlier timepoint which would not allow sufficient time for the laboratory values to change (or only detect patients with rapid changes) and a later time period such as 48 months, which meant patients with early outcomes, would be excluded. We believe using changes in laboratory values over a shorter time period (<24 months) in our model would underestimate the risk of a clinical outcome.

Conclusion: Shenling baizhusan can protect the damage in dextran

Conclusion: Shenling baizhusan can protect the damage in dextran sodium sulfate-induced IBD in mice,which

may be related to regulating inflammatory factor, scavenging oxygen free radicals and regulating ROCK/MLCK and MAPK/ERK pathway. Key Word(s): 1. Shenling baizhusan; 2. IBD; 3. ROCK/MLCK; 4. MAPK/ERK; Presenting Author: PENG YOU Additional Authors: JIANGYUAN WANG, YULAN LIU Corresponding Author: YULAN LIU Affiliations: Department of Gastroenterology,Peking University People’s Hospital Objective: To explore the current situation of medical therapy and compliance of ulcerative colitis (UC) patients in China. Methods: 258 cases (123 male and 135 female) of UC admitted to our hospital from all over China in the last Cisplatin in vitro 5 years were retrospective analyzed. Selection and delivery route of drugs in both initial and maintenance therapy and the adherence of patients were analyzed. Results: (1) The average age of onset is 41 years in male and 37 years in female. The average time from onset to definite diagnosis ranges from 0.2 to 312 months (14.6 months in average). (2) The highest percentage of drugs in initial therapy is quinolones, up to 39.3%, with an effective rate of 72.3%. The drug selection of oral SASP, oral 5-ASA, oral SASP + suppository and herbs is 52%, 14.6%, 13.5% and 7.3% respectively after

diagnosis. In maintenance therapy, 75.9% of cases used SASP or 5-ASA. The percentage of oral administration, suppository, oral administration + suppository, and enteroclysis is 65.7%, 11.8%, 12% and 2.8% respectively in maintenance therapy. (3) Compliance: the nonadherence rate is 50%, 69.2% and 100% in suppository, CHIR-99021 molecular weight oral and enteroclysis administration. The drug withdrawal occurs

7.7 months after the first remission in average. The average time of relapse after drug see more withdrawal is 11.9 months. The adherence rate of oral SASP, oral 5-ASA, suppository SASP and oral + suppository SASP is 35.7%, 24.1%, 11.6% and 10.7% respectively. Conclusion: (1) The diagnosis of UC is mainly based on colonoscopic examination, which should be performed earlier when UC is suspected. (2) There is a poor adherence rate of maintenance therapy when symptoms are relieved. Drug withdrawal mostly occurs half years after symptom remission. So follow-up and education of patients at that time is important. (3) SASP is very effective in maintenance therapy, and 5-ASA is not prior to SASP in compliance rate. SASP may have better cost efficient in China. Key Word(s): 1. ulcerative colitis; 2. medical therapy; 3. compliance; Presenting Author: WENYU JIANG Additional Authors: XIAOFEI ZHANG, HONGJIE ZHANG Corresponding Author: HONGJIE ZHANG Affiliations: The First Affiliated Hospital of Nanjing Medical University Objective: Inflammatory bowel disease (IBD) was believed to be caused by excessive and poorly controlled immune response. Experimental studies and data from recent clinical trials suggested that T cell-derived cytokines are crucial mediators of tissue damage.

This is also the first report to show that direct addition of RCA

This is also the first report to show that direct addition of RCA blockers into plasma samples from patients chronically infected with HCV render endogenous plasma virions sensitive to complement-mediated destruction. This strategy may be further Palbociclib datasheet developed in combination with the current standard of care for treatment of chronic HCV (pegylated

IFN-α plus ribavirin) to enhance therapy efficacy. We thank Apath (Brooklyn, NY) and Dr. Charles M. Rice at Rockefeller University (New York, NY) for JFH-1, pFL-J6/JFH, and Huh7.5.1 cells. Additional Supporting Information may be found in the online version of this article. “
“Background and Aim:  Confocal laser endomicroscopy (CLE) is a new endoscopy technique for subsurface analysis of the gastric mucosa and in vivo histology examination during endoscopy. We aimed to compare the clinical applicability and predictive power of CLE with the diagnosis of Helicobacter pylori infection in patients with gastrointestinal symptoms. Methods:  A total of 103 consecutive patients scheduled to undergo endoscopy were enrolled. CLE image criteria for H. pylori infection were established in a pilot study of 20 patients, then images for 83 consecutive patients were prospectively evaluated, and data were correlated with the final diagnosis of H. pylori infection in a blinded manner. Results: 

We found good association between histopathology and CLE findings. H. pylori infection was identified by CLE with

any of the NVP-AUY922 solubility dmso following three features: white spots, neutrophils and microabscesses. The accuracy, sensitivity and specificity of CLE diagnosis of H. pylori infection were 92.8%, 89.2% and 95.7%, respectively. The mean κ-value for interobserver agreement in the prediction of H. pylori infection was 0.78. Neutrophils were the best diagnostic feature and had good sensitivity (83.8%) and specificity (97.8%). H. pylori-associated changes were more common in the antrum than in the corpus among infected patients (P < 0.001). Conclusions: H. pylori infection can be identified by specific cellular and subcellular changes of the surface gastric mucosa with CLE. CLE is a novel, useful method for predicting H. pylori infection in vivo during endoscopy. Helicobacter pylori colonizes selleck chemical the gastric mucosa of over half of the world’s population, making it one of the most prevalent infections.1H. pylori infection is the major cause of gastritis, peptic ulcer, mucosa-associated lymphoid tissue lymphoma and gastric cancer.2 Correct diagnosis is therefore critical for treatment and to prevent potential complications. Recently, confocal laser endomicroscopy (CLE) has been developed to realize in vivo histology. CLE combines standard video endoscopy with confocal microscopy imaging of gastrointestinal mucosa during endoscopy.

7A), verifying the improvement of insulin signaling Consistently

7A), verifying the improvement of insulin signaling. Consistently, treatment of H4IIE cells with IsoLQ (5-20 μM) or LQ (10-100 μM) effectively prevented the serine phosphorylation http://www.selleckchem.com/products/CAL-101.html of IRS1 (Fig. 7B). The inhibition of IRS1 serine phosphorylation by IsoLQ or LQ was also confirmed in other cell models such as HepG2 cells, C2C12 myotubes, 3T3-L1 adipocytes, and primary rat hepatocytes (Fig. 7C). To further assess

the effect of IsoLQ or LQ on glucose homeostasis and insulin sensitivity, each agent was administered to mice fed an HFD: treatment of mice with the agents at the dose of 10 or 30 mg/kg/day for 5 days during the last 5 weeks of total 11 weeks of HFD feeding displayed a significantly improved glucose tolerance (2

g glucose/kg) compared to vehicle-treated control (Fig. 8A; normal diet [ND] and HFD controls were shared to simultaneously compare the compound effects), showing their effects on systemic insulin sensitivity. In mice fed an HFD for 9 weeks, IsoLQ treatment almost completely reduced fasting glucose, fasting serum insulin levels, and HOMA-IR values (Fig. 8B, upper). Similar results were obtained using Lepob/ob mice (Fig. 8B, lower). Our results indicate that licorice flavonoids have the ability to reduce obesity-induced insulin resistance. As a continuing effort to assess the effect of IsoLQ or LQ on insulin action, we measured glucose production and uptake in representative cell models. Incubation of HepG2 cells with each agent resulted in a significant decrease in glucose production, which IWR-1 research buy was comparable to that caused by insulin (Fig. 8C, left). TNF-α inhibited an increase in glucose uptake by insulin in C2C12 myotubes or differentiated 3T3-L1 adipocytes, which was also abrogated by IsoLQ treatment (Fig. 8C, middle and right). Our results indicate that IsoLQ (or LQ) treatment prevents glucose production from hepatocytes and stimulates glucose uptake into selleckchem muscle

cells or adipocytes. In HFD-fed mice, we measured the levels of glucose 6-phosphatase (G6Pase) mRNA as a marker of gluconeogenesis. IsoLQ or LQ treatment inhibited the G6Pase gene induction (Fig. 8D, upper). Consistently, either IsoLQ or LQ treatment antagonized the ability of cyclic adenosine monophosphate (cAMP) and dexamethasone to increase G6Pase mRNA levels in primary rat hepatocytes, as did insulin (Fig. 8D, lower). These results demonstrate that the inhibition of glucose production by IsoLQ or LQ may be mediated by the suppression of G6Pase. PTP1B negatively regulates insulin signaling by catalyzing the dephosphorylation of IR and IRS1/2.5 A decrease in PTP1B activity accompanies improved insulin sensitivity in obese subjects.18 In addition, evidence is accumulating that PTP1B polymorphisms in humans might be associated with insulin resistance.

Genetic links to hemochromatosis were first reported in 1976 and,

Genetic links to hemochromatosis were first reported in 1976 and, in 1996, a strong association was reported with the C282Y mutation in the HFE gene. Knowledge of the relationship between the mutation and excessive iron absorption is incomplete but involves up-regulation of the

divalent metal transporter protein, low levels of a polypeptide called hepcidin and up-regulation of a basolateral transport protein called ferroportin. Organs with the highest levels of transferrin receptors are at highest risk for damage by free radicals released by non-transferrin bound iron (free iron). Despite these important developments, most patients are treated by regular venesection, usually removal of 400-500 ml of blood that contains approximately Selleck STI571 250 mg of iron. The patient illustrated selleck inhibitor below was a woman, aged 53, who was investigated because of malaise and intermittent abdominal pain. On examination, she appeared to have prominent skin pigmentation. Liver function tests were abnormal and her serum ferritin was elevated at 834 µg/l. She subsequently developed symptoms of adrenal insufficiency and was commenced on steroid replacement therapy. Genetic testing revealed a homozygous C282Y mutation

while her liver biopsy showed grade 4 iron deposition mainly around the portal tracts. This has been highlighted in Figure 1 using a Perl’s stain. She did not have cirrhosis. Venesection on 41 occasions over 2 years resulted in a fall in ferritin to 28 µg/l. Over the subsequent 2 years, venesection was performed on 6 occasions and was associated with a serum ferritin of <50 µg/l. A liver biopsy selleck chemical was repeated 5 years after diagnosis and was normal without any evidence of iron deposition

(Perl’s stain, Figure 2). In hemochromatosis, the number of venesections required to achieve iron depletion is variable but, in one large study, the mean number was 85. Initially, all patients should have venesection at least once per week and, after iron depletion, at intervals of 1-3 months. There is now clear evidence that iron depletion improves prognosis. For example, in the absence of cirrhosis, treated patients with hemochromatosis have a similar life expectancy to that in the general population. Contributed by “
“Esophageal strictures can be caused by acid, radiation, eosinophilic esophagitis (EoE), and caustic injury. Food impaction in a young man warrants evaluation for eosinophilic esophagitis. Savary dilation is the most cost-effective therapy. Stricture dilation should be cautious (rule of threes) early on, especially in caustic, radiation and EoE strictures. Complex/resistant strictures may require steroid injections, incisional therapy, and stent placement. Complications of stricture treatment are rare. “
“We read with great interest the article by Bangarulingam et al.

[16, 17] RFA is one of the most recent local ablative therapies f

[16, 17] RFA is one of the most recent local ablative therapies for small HCC[13, 14, 18], which can be performed by percutaneous or surgical approach.[19-21] For small HCC nodules (less than 3 cm), there is still some controversy regarding to the long-term effectiveness between the two treatment modalities, such http://www.selleckchem.com/products/GDC-0980-RG7422.html as overall survive time, disease-free time, and the tumor recurrence rate.[13, 22] The aim of

this randomized study was to determine which treatment modality, hepatectomy, or percutaneous RFA is more beneficial for patients with small HCC in terms of long-term outcomes. One hundred twenty patients with HCC ≤ 3 cm between January 1, 2000 and December 30, 2012 were randomized into either percutaneous RFA therapy or hepatectomy group, as initial treatment Selleckchem Enzalutamide in Sir Run Run Shaw Hospital. Sixty patients who received hepatectomy were treated at Department of General Surgery, and 60 patients who received

RFA were treated in Department of Medical Oncology. The treatment and data collection were approved by Ethical Committee of our institution. HCC diagnosis was based on the criteria used by the European Association for the Study of the Liver, confirmed by a core biopsy before therapy. This study included 88 men and 32 women with a median age of 53.4 ± 10.9 years (range: 18–71). All patients were Chinese. Inclusion criteria as follows: (i) ≥ 18 years; (ii) any solitary HCC ≤ 3 cm in diameter and no more than three tumor nodules; (iii) no extrahepatic metastasis at diagnosis; (iv)

no radiologic evidence of major portal/hepatic vein branches invasion; (v) liver function equal or better than Pugh–Child Class B, with no history of encephalopathy, ascites refractory to diuretics or variceal bleeding (Patients with Pugh–Child Class C could be enrolled after the liver function was improved to B with the treatment options, including find more albumin infusion, diuretics, and non-steroidal anti-inflammatory drugs); and (vi) platelet count > 50 × 109/L without clinical significant portal hypertension and esophageal varices. We compared the randomized analysis based on the clinical characteristics, including age, sex, Child–Pugh classification, hepatic cirrhosis, tumor anatomical location, and HBV infection. Sixty patients underwent hepatectomy for HCC. Hepatectomy procedures were performed based on the position of HCC under general anesthesia, including nonanatomic hepatectomy in 38 patients, right hepatectomy in 13 patients, and left hepatectomy in 9 patients. A nonanatomic resection aiming at a resection margin of at least 2 cm was performed.